Table 2

Expression of membranous full-length (EpCAMMF) EpCAM and the truncated variant (EpCAMMT) in EpEX-positive tumours

Tumour entityEpCAMMFEpCAMMTχ2
n%n%
Pancreatic cancer (n=20)1365735NA
Prostate cancer (n=42)4197.612.4NA
Oesophageal cancer (n=15)1066.7533.3NA
Mesothelioma (n=4)410000NA
Gallbladder cancer (n=26)2284.6415.4NA
Cervical cancer (n=5)480120NA
Laryngeal cancer (n=5)510000NA
Hepatocellular carcinoma (n=6)583.3116.7NA
Colon
 Low-grade dysplasia (n=37)3491.938.10.024
 High-grade dysplasia (n=80)6682.51417.5
 Adenocarcinoma (n=33)2266.71133.3
Stomach
 Intestinal type cancer (n=35)1954.31645.70.180
 Diffuse cancer (n=9)666.7333.3
 Mixed histology (n=3)233.3166.7
 Small intestine cancer (n=14)964.3535.7NA
Endometrium
 Endometrioid carcinoma (n=32)1237.52062.50.961
 Serous carcinoma (n=24)1145.81354.2
 Urinary bladder cancer (n=23)1147.81252.2NA
Lung
 Adenocarcinoma (n=49)3877.61122.30.034
 Bronchoalveolar carcinoma (n=5)120480
 Squamous cell carcinoma (n=18)1477.8422.2
 Large cell carcinoma (n=8)787.5112.5
 SCLC (n=24)2083.3416.7
Ovarian
 Endometrioid cancer (n=27)2074.1725.90.180
 Serous cancer (n=27)2177.8622.2
 Mucinous cancer (n=10)1010000
Breast
 Ductal carcinoma (n=11)981.8218.20.815
 Mucinous carcinoma (n=7)710000
 Tubular carcinoma (n=3)310000
 Medullary carcinoma (n=31)2890.339.7
 Lobular carcinoma (n=6)583.3116.7
Parotid gland
 Pleomorphic adenoma (n=14)642.9857.10.001
 Adenolymphoma (n=17)423.51376.5
 Cylindroma (n=11)1090.919.1
Well-differentiated NET (n=23)1982.6417.4NA
Thymoma (n=9)888.9110.1NA
Total (n=713)52673.818726.2
  • NA, Not applicable.